© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
The drug can quickly reverse opioid-driven overdoses.
A recent study of people in British Columbia found, however, that people who inject drugs had lower cure rates.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
Additionally, in a recent study, having hep C mutations associated with resistance didn’t affect the outcome of treatment.
Highlights from research presented at the 52nd International Liver Congress in Amsterdam
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
